Get all your news in one place.

100’s of premium titles.
One app.

Start reading

Get all your news in one place.

100’s of premium titles. One news app.

Start reading

The Latest Breaking News from TransMedics

TransMedics, F5 Lead Big Overnight Earnings Winners, Losers

With earnings season in full swing, big winners and losers abound. TransMedics and F5 were notable movers Monday night.

Investors Business Daily

Dow Jones Futures: Meta, Apple, Tesla Lead New Buys In Big Rally. Pay Attention To This Key Shift.

The Dow Jones and S&P 500 hit new highs and the Nasdaq topped key levels as growth led the day 2 reaction to Fed rate cuts.

Investors Business Daily

Dow Jones Futures: Market Rally Still Must Do This; Nvidia Chipmaker's Sales Boom

The market rally attempt hasn't proved itself yet. Meta leads stocks near buy points. Nvidia chipmaker TSMC reported strong sales.

Investors Business Daily

From analysis to the latest developments in health,
read the most diverse news in one place.

Dow Jones Futures Fall As Fed Looms; Amazon Rises As AMD, Super Micro Plunge

The market rally stumbled ahead of the Fed meeting. Amazon rose on earnings while AI plays Super Micro and AMD plunged.

Investors Business Daily

Heart And Lung Transplants Drive Medical Stock Higher As S&P 500 Fizzles

Organ transplant firm TransMedics has soared past a buy point amid a six-day rally even as the S&P 500 has come off its recent highs.

Investors Business Daily

Organ Transplant Leader TransMedics Eyes New Buy Point After 800% Advance

Among the best stocks to buy and watch, organ transplant leader TransMedics has a fresh buy point after an 800% advance since February 2022.

Investors Business Daily

Research: Livers Can Stay Functional For Over 100 years

According to researchers from the University of Texas (UT) Southwestern Medical Center, Dallas, and TransMedics, Andover, Massachusetts, there is a small, but growing, subset of livers that have been transplanted and have a cumulative age of more than 100 years.Read more on Dynamite News:

Dynamite News

Read news from The Economist, FT, and more,
with one subscription

TransMedics Stock Skyrockets On Increased 2022 Guidance

TransMedics Group Inc (NASDAQ:TMDX) shares got a massive boost after better than expected Q1 earnings and 2022 guidance. The company posted an EPS loss of $(0.38) in line with expectations and higher than $(0.29) a year ago despite more than doubling its sales from Q1 FY21. Net revenue of $15.9 million increased 125%…

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations